Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2025-12-24 @ 10:32 PM
NCT ID:
NCT00418535
Eligibility Criteria:
Inclusion Criteria:
* Pathologically confirmed NK/T-cell lymphoma
* Localized (Ann Arbor stage I/II) disease
* At least one measurable lesion
* Age \> 18
* ECOG performance status 0 - 2
* Expected life span of at least 12 weeks
* Normal marrow function (hemoglobin ≥ 9.0 g/dL; absolute neutrophil count ≥ 1,500/mm3; platelet count ≥ 100,000/mm3)
* Normal liver function (total bilirubin \< 2x upper limit of normal \[ULN\], transaminase \< 3x ULN)
* Normal renal function (serum creatinine ≤ 1.5 mg/dL, creatinine clearance ≥ 50 mL/min)
* Written informed consent
Exclusion Criteria:
* Other malignancies except for treated non-melanoma skin cancers and cervical cancer in situ
* Serious medical illnesses (congestive heart failure, angina, respiratory failure, and renal failure)
* Acute or active infection requiring intravenous (IV) antibiotics
* Pregnant, lactating women
* Previous history of chemotherapy or radiotherapy
* Concomitant medication that may influence the study drugs
* Allergic reaction to study drugs
* Grade 2 or greater peripheral neuropathy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00418535
Study Brief:
Protocol Section:
NCT00418535